Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 Oct;24(5):670-680.
doi: 10.1007/s11102-021-01142-7. Epub 2021 Mar 29.

Diagnosis and treatment outcomes of Cushing's disease during pregnancy

Kalyani Sridharan  1 , Jayaprakash Sahoo  2 , Rajan Palui  3 , Milind Patil  4 , Sadishkumar Kamalanathan  2 , A S Ramesh  5 , N S Kubera  6
Affiliations
Case Reports

Diagnosis and treatment outcomes of Cushing's disease during pregnancy

Kalyani Sridharan et al. Pituitary. 2021 Oct.

Abstract

Purpose: We report a case of a pregnant woman with Cushing's disease (CD) and performed a systematic review of literature on diagnosis, treatment, maternal and fetal outcomes of CD in pregnancy.

Methods: A PubMed search was performed for manuscripts in English language from inception till June 2020. Cases of CD with hypercortisolism during pregnancy were included and categorized into three groups based on treatment received. Data on diagnostic modalities, CD remission, materno-fetal outcomes were analysed.

Results: Fifty-five patients of CD with 62 pregnancies were analysed. 24-h urinary free cortisol(UFC) was elevated by a mean of 5.4 ± 4.2 fold upper limit of normal non-pregnant level. 12/19 (63.1%) CD patients had more than threefold elevation of UFC measured during pregnancy. Mean midnight serum cortisol was 753.7 ± 270.5 nmol/l. At a midnight serum cortisol cut off of 440 nmol/l, 15/16 patients were correctly identified as CD. 23.2% underwent trans-sphenoidal surgery (group 1), 16.1% received only medical treatment (group 2) while 60.7% received no treatment (group 3) during pregnancy. Remission rates for CD in groups 1 and 2 were 76.9% and 77.8%, respectively. Adverse maternal and fetal outcomes were seen in 53.9% and 59.3% of the patients, respectively and were not significantly different between groups, although, lesser live births and greater pregnancy losses were seen in group 3.

Conclusion: Midnight serum cortisol had better sensitivity than UFC for diagnosing hypercortisolism due to CD during pregnancy. In general, CD should be treated during pregnancy in order to optimize maternal and fetal outcomes as a trend towards increased live births is seen in treated subjects.

Keywords: Cushing’s disease; Cushing’s syndrome; Pregnancy; Trans-sphenoidal surgery.

PubMed Disclaimer

References

    1. Hunt AB, McConahey WM (1953) Pregnancy associated with diseases of the adrenal glands. Am J Obstet Gynecol 66:970–987 - DOI
    1. Caimari F, Valassi E, Garbayo P et al (2017) Cushing’s syndrome and pregnancy outcomes: a systematic review of published cases. Endocrine 55:555–563. https://doi.org/10.1007/s12020-016-1117-0 - DOI - PubMed
    1. Buescher MA, McClamrock HD, Adashi EY (1992) Cushing syndrome in pregnancy. Obstet Gynecol 79:130–137 - PubMed
    1. Lindsay JR, Jonklaas J, Oldfield EH, Nieman LK (2005) Cushing’s syndrome during pregnancy: personal experience and review of the literature. J ClinEndocrinol Metab 90:3077–3083. https://doi.org/10.1210/jc.2004-2361 - DOI
    1. Bronstein MD, Machado MC, Fragoso MCBV (2015) Management OF endocrine disease: management of pregnant patients with Cushing’s syndrome. Eur J Endocrinol 173:R85–R91. https://doi.org/10.1530/EJE-14-1130 - DOI - PubMed

LinkOut - more resources